India's CSIR, Mylan Make to Collaborate on COVID-19 Therapies, an Industrial Info Market Brief
India's CSIR, Mylan Make to Collaborate on COVID-19 Therapies, an Industrial Info Market Brief
Attachment: Mylan
The Council of Scientific & Industrial Research (CSIR), India's premier research organization, and Mylan Laboratories Limited, the India-based subsidiary of global pharma giant Mylan, on Thursday announced a partnership to address unmet patient needs amidst the evolving COVID-19 pandemic.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
